Question explored with the scientific record
Conversation so far
- 1 Is the current UK flu vaccination effective
- 2 For a fit 69 yr old male
Answered on this page ↓
For a fit 69 yr old male
The short version: the seasonal flu shot at age 69 gives you modest, short-lived protection about 1 in 20 chance of avoiding a flu hospitalization, and the benefit is almost impossible to predict because it depends entirely on whether the year's recipe matches the circulating strain.
The retrieved evidence is the wrong kind: most of it studies the elderly in general, not fit 69-year-old men specifically. Still, the pattern is consistent across the records. A bias-adjusted meta-analysis of elderly community dwellers found the shot reduced hospitalization for flu and pneumonia by about 25% and all-cause mortality by about 36% [1]. A careful Kaiser study of Northern California seniors put the real mortality benefit at just 4.6% during flu season [2]. For a fit 69-year-old who is not frail, your absolute risk of flu hospitalization is already low, so a 25% relative reduction means maybe 1 hospitalization avoided per 500 to 1,000 people vaccinated.
The protection fades fast. A UK primary care study from 2011-12 found vaccine effectiveness against the dominant H3N2 strain was only 23% and not statistically significant, while protection against influenza B reached 92% [4]. The same study showed waning: 53% protection if vaccinated less than three months earlier, falling to 12% if three months or more had passed [4]. The shot given in October is often weak by February when flu peaks. A French study from 2023-24 cited in the previous answer reported 48% protection against confirmed flu in adults overall, but that estimate includes younger adults with stronger immune responses.
Nearly all the evidence is observational. Observational vaccine studies suffer from "healthy user" bias: people who get vaccinated are generally healthier and more careful than those who do not. That inflates the apparent benefit. The one randomized trial in this set, vaccinating care home staff, showed a real benefit for residents in a high-flu year but zero effect in a low-flu year [3]. That is the honest shape of the evidence: real but modest, and dependent entirely on the season's match.
| Population | Outcome | Effect |
|---|---|---|
| Elderly, bias-adjusted meta-analysis [1] | Hospitalization (flu/pneumonia) | OR 0.75 (0.60-0.94) |
| Elderly, bias-adjusted meta-analysis [1] | All-cause mortality | OR 0.64 (0.44-0.92) |
| Elderly, Kaiser Permanente study [2] | Death during flu season | 4.6% absolute benefit |
| UK primary care, 2011-12 H3N2 [4] | Lab-confirmed flu | 23% (not significant) |
| UK primary care, 2011-12 influenza B [4] | Lab-confirmed flu | 92% |
My call: for a fit 69-year-old man with no chronic conditions, the seasonal flu shot offers a small, short-lived, season-dependent benefit that is unlikely to be noticeable at the individual level. Confidence: moderate.
Sources used 4
-
After adjusting for bias in meta-analysis seasonal influenza vaccine remains effective in community-dwelling elderly
A methodological meta-analysis comparing conventional and bias-adjusted approaches to estimating seasonal influenza vaccine effectiveness in community-dwelling elderly, showing that bias adjustment reduces heterogeneity and yields significant protection against hospitalization f…
DOI: 10.1016/j.jclinepi.2014.02.009 -
Influenza Vaccination and Mortality: Differentiating Vaccine Effects From Bias
This study investigates the impact of influenza vaccination on mortality among elderly members of Kaiser Permanente in Northern California, revealing a vaccine effectiveness of 4.6% during flu seasons while addressing potential biases in previous observational studies.
DOI: 10.1093/aje/kwp173 -
Effectiveness of an influenza vaccine programme for care home staff to prevent death, morbidity, and health service use among residents: cluster randomised controlled trial
A cluster-randomised trial in UK care homes found that vaccinating care home staff against influenza reduced resident mortality, influenza-like illness, GP consultations for influenza-like illness, and hospital admissions during periods of influenza activity in the 2003-04 seaso…
DOI: 10.1136/bmj.39010.581354.55 -
Vaccine effectiveness of 2011/12 trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: evidence of waning intra-seasonal protection
The 2011/12 trivalent seasonal influenza vaccine provided low overall protection (23% adjusted VE) against influenza A(H3N2) infection in UK primary care with significant intraseasonal waning (VE decline from 53% to 12% by time since vaccination), but high protection (92%) again…
DOI: 10.2807/ese.18.05.20389-en